HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Chang Jiang Selected Research
Chang Jiang Research Topics
Disease
29
Neoplasms (Cancer)
11/2022 - 01/2014
16
Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 01/2014
6
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2022 - 02/2020
6
Osteonecrosis (Kienbock's Disease)
01/2022 - 11/2019
6
Colonic Neoplasms (Colon Cancer)
04/2019 - 01/2015
5
Breast Neoplasms (Breast Cancer)
01/2022 - 01/2015
5
Neoplasm Metastasis (Metastasis)
01/2021 - 01/2016
4
Inflammation (Inflammations)
01/2022 - 11/2018
3
Osteoporosis
11/2022 - 12/2013
3
Nasopharyngeal Carcinoma
05/2022 - 05/2019
3
Triple Negative Breast Neoplasms
01/2022 - 01/2017
3
Spinal Cord Injuries (Spinal Cord Injury)
01/2021 - 12/2019
3
Burkitt Lymphoma (Burkitt's Lymphoma)
10/2020 - 01/2017
2
Adenocarcinoma of Lung
11/2022 - 01/2021
2
Intervertebral Disc Degeneration
10/2022 - 01/2021
2
Type 2 Diabetes Mellitus (MODY)
06/2022 - 01/2020
2
Developmental Dysplasia of the Hip
01/2022 - 12/2021
2
Starvation
12/2021 - 01/2021
2
Wounds and Injuries (Trauma)
01/2021 - 09/2012
2
Carcinoma (Carcinomatosis)
01/2021 - 01/2018
2
Anemia
05/2019 - 01/2015
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2022
1
Iron Overload
11/2022
1
Hyperglycemia
10/2022
1
Insulin Resistance
06/2022
1
Weight Loss (Weight Reduction)
05/2022
1
Malignant Mesothelioma
01/2021
1
Intellectual Disability (Idiocy)
10/2020
1
alpha-Thalassemia
10/2020
1
Pathologic Processes
08/2020
1
Lymphoma (Lymphomas)
01/2020
Drug/Important Bio-Agent (IBA)
9
Proteins (Proteins, Gene)
FDA Link
11/2022 - 01/2017
7
Bevacizumab (Avastin)
FDA Link
01/2020 - 01/2014
6
Biomarkers (Surrogate Marker)
IBA
01/2022 - 01/2014
5
Iron
IBA
11/2022 - 01/2021
5
Glucocorticoids
IBA
01/2022 - 11/2019
3
Antigens
IBA
10/2020 - 01/2017
3
Profilins (Profilin)
IBA
10/2018 - 01/2015
2
Glutathione (Reduced Glutathione)
IBA
11/2022 - 01/2021
2
Glucose (Dextrose)
FDA Link
Generic
10/2022 - 01/2020
2
Indicators and Reagents (Reagents)
IBA
01/2022 - 01/2019
2
Lipids
IBA
11/2021 - 01/2015
2
oxidized low density lipoprotein
IBA
11/2021 - 01/2015
2
DNA (Deoxyribonucleic Acid)
IBA
02/2021 - 01/2020
2
MicroRNAs (MicroRNA)
IBA
01/2021 - 12/2019
2
Long Noncoding RNA
IBA
01/2021 - 01/2021
2
Oxidoreductases (Dehydrogenase)
IBA
01/2020 - 01/2016
2
Cetuximab (Erbitux)
FDA Link
01/2020 - 04/2019
2
Biological Products
IBA
01/2020 - 01/2017
2
Oncogene Proteins (Oncogene Protein)
IBA
01/2020 - 05/2017
2
Immune Checkpoint Inhibitors
IBA
02/2019 - 01/2018
2
C-Reactive Protein
IBA
01/2019 - 01/2018
2
Carbohydrates
IBA
01/2019 - 01/2017
2
Albumins
IBA
01/2019 - 11/2018
2
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
01/2018 - 01/2017
2
Carcinoembryonic Antigen
IBA
01/2016 - 01/2014
1
Immune Checkpoint Proteins
IBA
11/2022
1
Reactive Oxygen Species (Oxygen Radicals)
IBA
11/2022
1
Malondialdehyde (Propanedial)
IBA
11/2022
1
Ligands
IBA
11/2022
1
ferrostatin-1
IBA
11/2022
1
Superoxide Dismutase
IBA
11/2022
1
Deferoxamine (Desferal)
FDA Link
Generic
11/2022
1
Dextrans (Dextran)
FDA Link
11/2022
1
ferric ammonium citrate
FDA Link
11/2022
1
Metformin (Glucophage)
FDA Link
Generic
06/2022
1
Proteoglycans (Proteoglycan)
IBA
01/2022
1
ferric citrate iron reductase (ferric-chelate reductase)
IBA
12/2021
1
Transferrin (beta 2 Transferrin)
IBA
12/2021
1
B7-H1 Antigen
IBA
08/2021
1
Peptides (Polypeptides)
IBA
01/2021
1
Cysteine (L-Cysteine)
FDA Link
01/2021
1
Cystine (L-Cystine)
IBA
01/2021
1
Glutamate-Cysteine Ligase
IBA
01/2021
1
Protective Agents
IBA
01/2021
1
Glutamic Acid (Glutamate)
FDA Link
01/2021
1
RNA (Ribonucleic Acid)
IBA
01/2021
1
Steroids
IBA
01/2021
1
Histone Chaperones
IBA
10/2020
1
Histones (Histone)
IBA
10/2020
1
Chromatin
IBA
10/2020
1
Endoplasmic Reticulum Chaperone BiP
IBA
01/2020
1
Streptozocin (Streptozotocin)
FDA Link
01/2020
1
Hematoxylin (Haematoxylon)
IBA
01/2020
1
HMPL-013
IBA
01/2020
1
Blood Glucose (Blood Sugar)
IBA
01/2020
1
Cyclic Peptides
IBA
01/2020
1
Caspase 12
IBA
01/2020
1
Eosine Yellowish-(YS) (Eosin)
IBA
01/2020
Therapy/Procedure
10
Therapeutics
11/2022 - 12/2013
9
Drug Therapy (Chemotherapy)
01/2022 - 01/2015
4
Immunotherapy
01/2022 - 01/2019
3
Radiotherapy
05/2022 - 02/2021
2
Hip Replacement Arthroplasty (Total Hip Replacement)
01/2022 - 12/2021
2
Adjuvant Chemotherapy
01/2021 - 11/2017
2
Chemoradiotherapy
02/2020 - 05/2019
1
Glycemic Control
10/2022
1
Osteotomy
12/2021
1
Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
02/2021
1
Consolidation Chemotherapy
02/2020